Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

類似資料

• A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response
  著者:: De Wolf, Katrien, 等
  出版事項: (2017)
• Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures
  著者:: Meireson, Annabel, 等
  出版事項: (2021)
• Reply to ‘Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma’
  著者:: Jacquelot, Nicolas, 等
  出版事項: (2018)
• Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile
  著者:: Meireson, Annabel, 等
  出版事項: (2018)
• IDO Expression in Cancer: Different Compartment, Different Functionality?
  著者:: Meireson, Annabel, 等
  出版事項: (2020)